MGI Virtual Xpert: Introduction to DNBSEQ-G400: Comprehensive and Flexible Genome Sequencer
Aug 3, 2023
Share article
#MGI Virtual Xpert - our new learning centre, localised all educational resources, technologies, and application areas.
With this episode, learn about the most flexible high-performance genome sequencers at MGI: Our DNBSEQ-G400
DNBSEQ-G400: Revolutionizing Genome Sequencing with Unmatched Versatility and Speed
Advancements in Life Science Innovation
Focusing on the biotech industry, MGI specializes in R&D, production and sales of equipment and instruments, reagents, and related products to support life science research in a wide range of frontier applications, including precision medicine, precision agriculture, precision healthcare, and more. At MGI, we are working on the improvement of the availability of genomic technologies by providing customers with core tools for life science research and applications.
MGI Patented DNBSEQ™ Technology – Enhancing Accuracy
DNBSEQ™ provides the advantages of low amplification error rates from DNBs and high-density Patterned Arrays to significantly improve the accuracy of sequencing with a low repetition rate.
Combined with the PCR-free library preparation approach, it reduces the error of entry during amplification and greatly improves the accuracy of detecting SNPs and indels.
DNBSEQ - G400 is a comprehensive and versatile benchtop sequencer for medium to large genome sequencing projects, supporting five read lengths covering applications from fertility testing and rapid pathogen detection to tumor detection, transcriptome, WGBS, WES and WGS
Watch the new episode of #MGI Virtual Xpert to learn more about DNBSEQ-G400:
Strengthen your daily sequencing capabilities with DNBSEQ-G400
DNBSEQ-G400 is a versatile benchtop sequencer providing users with comprehensive, flexible and efficient sequencing options. DNBSEQ-G400 sequencer supports a wide range of applications, including scientific research, clinical research, disease prevention, environment studies and agriculture, etc., increasing the popularity of high-throughput sequencing systems in medical and scientific research fields.
Output: 55 Gb~1440 Gb per run
Flow cells: Small with 550M reads, or Large 1500-1800M with reads with 2 or 4 lanes
Read Length: SE50, SE100, SE400, PE100, PE150, PE200, PE300
Applications: Highest flexibility for all research applications, including WGS, WES and RNA sequencing
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
DNA SEQUENCING
MGI SEQUENCING
GENOME SEQUENCERS
HIGH-PERFORMANCE
Share this article :
Share